Carta científica
Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2
Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease
A. González-Castro
, E. Cuenca Fito, A. Fernandez, P. Escudero Acha, J.C. Rodríguez Borregán, Y. Peñasco
Autor para correspondencia
Servicio de Medicina Intensiva, Hospital Universitario Marqués de Valdecilla, Santander, España
Leído
9023
Vecesse ha leído el artículo
1979
Total PDF
7044
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 7 | 0 | 2 | 2 |
| 2025 6 | 10 | 37 | 47 |
| 2025 5 | 238 | 61 | 299 |
| 2025 4 | 191 | 53 | 244 |
| 2025 3 | 181 | 55 | 236 |
| 2025 2 | 231 | 48 | 279 |
| 2025 1 | 208 | 67 | 275 |
| 2024 12 | 176 | 62 | 238 |
| 2024 11 | 217 | 82 | 299 |
| 2024 10 | 161 | 68 | 229 |
| 2024 9 | 215 | 59 | 274 |
| 2024 8 | 281 | 48 | 329 |
| 2024 7 | 246 | 34 | 280 |
| 2024 6 | 250 | 97 | 347 |
| 2024 5 | 190 | 68 | 258 |
| 2024 4 | 173 | 56 | 229 |
| 2024 3 | 168 | 42 | 210 |
| 2024 2 | 175 | 47 | 222 |
| 2024 1 | 223 | 37 | 260 |
| 2023 12 | 243 | 43 | 286 |
| 2023 11 | 234 | 83 | 317 |
| 2023 10 | 250 | 60 | 310 |
| 2023 9 | 225 | 74 | 299 |
| 2023 8 | 163 | 34 | 197 |
| 2023 7 | 178 | 45 | 223 |
| 2023 6 | 148 | 35 | 183 |
| 2023 5 | 190 | 45 | 235 |
| 2023 4 | 116 | 27 | 143 |
| 2023 3 | 162 | 51 | 213 |
| 2023 2 | 137 | 54 | 191 |
| 2022 1 | 187 | 58 | 245 |
| 2022 12 | 139 | 58 | 197 |
| 2022 11 | 134 | 50 | 184 |
| 2022 10 | 215 | 55 | 270 |
| 2022 9 | 202 | 72 | 274 |
| 2022 8 | 183 | 57 | 240 |
| 2022 7 | 43 | 5 | 48 |
| 2022 6 | 68 | 2 | 70 |
| 2022 5 | 119 | 23 | 142 |
| 2022 4 | 17 | 0 | 17 |
| 2022 3 | 23 | 2 | 25 |
| 2022 2 | 15 | 2 | 17 |
| 2021 1 | 17 | 0 | 17 |
| 2021 12 | 21 | 0 | 21 |
| 2021 11 | 7 | 2 | 9 |
| 2021 9 | 1 | 0 | 1 |
| 2021 7 | 1 | 2 | 3 |
| 2021 6 | 2 | 2 | 4 |
| 2021 5 | 26 | 5 | 31 |
| 2021 4 | 44 | 10 | 54 |
Mostrar todo
